Bladder Cancer Index (BCI)

TECHNOLOGY NUMBER: 2020-074
Technology No. 2020-074
BCI
1

OVERVIEW

Health related quality of life measure for patients diagnosed with bladder cancer with emphasis on treatment related patient reported outcomes in the urinary, bowel and sexual domains

  • Quality of life Measure
  • Open Access - Creative Commons Attribution-NonCommercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0)

BACKGROUND

The Bladder Cancer Index (BCI) was developed by researchers at the University of Michigan to measure health related quality of life among men with bladder cancer. It represents an adaptation of the UCLA Prostate Cancer Index, modified to enhance sensitivity to therapy effects by increasing the number of prostate-targeted items to 50 (compared to 20 in the original UCLA-PCI). 

Original THE JOURNAL OF UROLOGY 2010 Paper can be found here.

ADDITIONAL DETAILS

(c) 2010 The Regents of the University of Michigan The Bladder Cancer Index (BC) is licensed under the Creative Commons Attribution-No Derivatives 4.0 International (CC BY-ND 4.0) License.

  • swap_vertical_circlecloud_downloadSupporting documents (1)
    Product brochure
    Bladder Cancer Index (BCI).pdf
    DOWNLOAD
    Additional files may be available once you've completed the transaction for this product. If you've already done so, please log into your account and visit My account / Downloads section to view them.
2020-074: Bladder Cancer Index (CC BY-ND 4.0)
This license includes digital files, available for download after the license agreement has been executed and approved (if necessary).

Term: perpetual

Free of charge

Questions about this technology?
Contact us